Tracon Pharmaceuticals Inc Quick Ratio (TCON) starting from the second quarter 2024 to second quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Tracon Pharmaceuticals Inc   (TCON)

Tracon Pharmaceuticals Inc 's Quick Ratio

TCON's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2024, Quick Ratio deteriorated to 0.63 below Tracon Pharmaceuticals Inc 's average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry 133 other companies have achieved higher Quick Ratio than Tracon Pharmaceuticals Inc in second quarter 2024. While Quick Ratio total ranking has improved so far during the Q2 2024 to 2052, from total ranking in the first quarter 2024 at 2085.

Explain Quick Ratio?
How much Cash & cash equivalents TCON´s has?
What are TCON´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TCON Quick Ratio (Jun 30 2024)
Q2		 (Mar 31 2024)
Q1		 (Dec 31 2023)
Q4		 (Sep 30 2023)
Q3		 (Jun 30 2023)
Q2
Y / Y Current Liabilities Change -63.47 % 467.93 % -40.07 % -15.82 % 2451.65 %
Y / Y Cash & cash equivalent Change 261.38 % 19.38 % -50.87 % -54.43 % -87.22 %
Quick Ratio MRQ 0.63 0.76 0.84 7.19 0.06
TCON's Total Ranking # 2052 # 2085 # 1782 # 476 # 3747
Seq. Current Liabilities Change -5.35 % 2.63 % 842.78 % -96.01 % 1371.36 %
Seq. Cash & cash equivalent Change -20.54 % -7.86 % 10.32 % 347.44 % -73.75 %



Quick Ratio second quarter 2024 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 134
Healthcare Sector # 716
Overall Market # 2052


Quick Ratio Statistics
High Average Low
65 7.22 0.06
(Jun 30 2018)   (Jun 30 2023)




Financial Statements
Tracon Pharmaceuticals Inc 's Current Liabilities $ 10 Millions Visit TCON's Balance sheet
Tracon Pharmaceuticals Inc 's Cash & cash equivalent $ 6 Millions Visit TCON's Balance sheet
Source of TCON's Sales Visit TCON's Sales by Geography


Cumulative Tracon Pharmaceuticals Inc 's Quick Ratio

TCON's Quick Ratio for the trailling 12 Months

TCON Quick Ratio

 (Jun 30 2024)
12 Months		 (Mar 31 2024)
12 Months		 (Dec 31 2023)
12 Months		 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth -33.03 % 130.39 % 92.7 % 238.06 % 198.24 %
Y / Y Cash & cash equivalent TTM Growth -28.79 % -52.52 % -61.86 % -52.98 % -52.13 %
Quick Ratio TTM 0.96 0.53 0.61 0.71 0.91
Total Ranking TTM # 3577 # 3450 # 3464 # 316 # 3440
Seq. Current Liabilities TTM Growth -35.22 % 21.43 % -14.49 % -0.43 % 122.84 %
Seq. Cash & cash equivalent TTM Growth 17.47 % 5.19 % -26.44 % -21.66 % -21.67 %

Quick ratio ranking by company, industry and sector >> Back to TCON Financial Strength Comparisons >> Go to Compare TCON Quick Ratio to its Competitors

On the trailing twelve months basis TCON Cash & cash equivalent more than doubled by 261.38 % in Q2 2024 year on year, while Current Liabilities decreased to $10 millions, this led to increase in in Tracon Pharmaceuticals Inc 's Quick Ratio to 0.96, Quick Ratio remained below TCON average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 157 other companies have achieved higher Quick Ratio than Tracon Pharmaceuticals Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2024 from 3450 to 3577.

Explain Quick Ratio?
How much Cash & cash equivalents TCON´s has?
What are TCON´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 158
Healthcare Sector # 961
Within the Market # 3577


trailing twelve months Quick Ratio Statistics
High Average Low
4.02 2.23 0.39
(Sep 30 2017)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2024, within Biotechnology & Pharmaceuticals Industry Quick RatioJun 30 2024 MRQ Cash & cash equivalentJun 30 2024 MRQ Current Liabilities
Candel Therapeutics Inc   1.59 $ 21.454  Millions$ 13.457  Millions
ADAPTIN BIO, INC.  1.51 $ 0.250  Millions$ 0.166  Millions
Curis Inc   1.46 $ 28.360  Millions$ 19.366  Millions
Halozyme Therapeutics Inc   1.41 $ 187.864  Millions$ 133.360  Millions
C4 Therapeutics Inc   1.35 $ 73.114  Millions$ 54.201  Millions
Argenx Se  1.25 $ 1,438.247  Millions$ 1,149.745  Millions
Vaxart Inc   1.23 $ 19.308  Millions$ 15.756  Millions
Alpha Cognition Inc.  1.18 $ 2.038  Millions$ 1.725  Millions
Aim Immunotech Inc   1.17 $ 10.061  Millions$ 8.608  Millions
Genfit S a   1.09 $ 91.603  Millions$ 84.181  Millions
Intensity Therapeutics Inc   1.02 $ 3.241  Millions$ 3.177  Millions
Valneva Se  0.96 $ 188.464  Millions$ 195.943  Millions
Bio techne Corp  0.95 $ 152.863  Millions$ 160.951  Millions
Redwoods Acquisition Corp  0.94 $ 0.845  Millions$ 0.899  Millions
Mink Therapeutics Inc   0.92 $ 9.314  Millions$ 10.147  Millions
Novavax inc   0.91 $ 1,049.594  Millions$ 1,157.811  Millions
Cellectis S a   0.90 $ 149.042  Millions$ 166.325  Millions
Ocugen Inc   0.87 $ 15.697  Millions$ 17.972  Millions
Outlook Therapeutics Inc   0.75 $ 32.024  Millions$ 42.522  Millions
Sangamo Therapeutics Inc   0.71 $ 27.786  Millions$ 39.005  Millions
Mesoblast Limited  0.67 $ 38.029  Millions$ 56.932  Millions
Tracon Pharmaceuticals Inc   0.63 $ 6.270  Millions$ 9.891  Millions
Elutia Inc   0.53 $ 18.188  Millions$ 34.610  Millions
Bluebird Bio Inc   0.48 $ 144.067  Millions$ 297.930  Millions
Brainstorm Cell Therapeutics inc   0.45 $ 3.469  Millions$ 7.691  Millions
Ladrx Corporation  0.45 $ 0.817  Millions$ 1.828  Millions
Dbv Technologies S a   0.43 $ 12.688  Millions$ 29.255  Millions
Amgen Inc   0.43 $ 9,301.000  Millions$ 21,517.000  Millions
Protalix Biotherapeutics inc   0.40 $ 23.399  Millions$ 57.972  Millions
Champions Oncology Inc   0.39 $ 2.892  Millions$ 7.483  Millions

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.